BioSpace News Archive

Press Releases

Avidity Biosciences Receives Orphan Drug Designation in Japan for Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1

April 8, 2025
·
9 min read
Press Releases

SciTech Development Announces 2nd FDA Approval of a Phase 1 a/b IND For ST-001. New IND Targets the Treatment of Relapsed/Refractory Small Cell Lung Cancer Following Its Previous Approval in the Treatment of T-Cell NHL

April 8, 2025
·
3 min read
Press Releases

BostonGene Appoints Dr. Ferran Prat as Chief Commercial Officer

April 8, 2025
·
2 min read
Press Releases

Defence Launches Accum Combined with Actinium-225 to Increase Efficacy and Safety of Radio-Immunoconjugate Cancer Therapies

April 8, 2025
·
4 min read
Press Releases

City of Hope Study Demonstrates Proof of Concept for Targeted New Approach to Treat Pancreatic Cancer

April 8, 2025
·
5 min read
Press Releases

Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia

April 8, 2025
·
7 min read
Press Releases

Scientist.com Launches Clinical Labs Navigator™ to Expand Clinical Sourcing Capabilities

April 8, 2025
·
1 min read
Press Releases

ImmunityBio Announces Execution of $75 Million Equity Financing with an Institutional Investor

April 8, 2025
·
5 min read
Press Releases

Science 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma Trial

April 8, 2025
·
2 min read
Press Releases

CardioVia Announces FDA Clearance for ViaOne, Opening a New Frontier in Minimally Invasive Heart-Surface Treatments

April 8, 2025
·
2 min read